Valuation: Danaher Corporation

Market Cap 160B 143B 131B 120B 224B 15,184B 229B 1,569B 633B 8,014B 602B 589B 25,313B P/E 2026 *
36.2x
P/E 2027 * 30.3x
Enterprise Value 181B 162B 148B 135B 253B 17,132B 258B 1,771B 714B 9,042B 679B 665B 28,561B EV / Sales 2026 *
6.89x
EV / Sales 2027 * 6.24x
Free-Float
70.57%
Yield 2026 *
0.64%
Yield 2027 * 0.69%
1 day-1.83%
1 week-2.15%
Current month-1.83%
1 month+6.50%
3 months+16.92%
6 months+30.16%
Current year-0.41%
1 week 227.53
Extreme 227.53
238.46
1 month 211.72
Extreme 211.715
238.46
Current year 160.93
Extreme 160.93
242.8
1 year 160.93
Extreme 160.93
242.8
3 years 160.93
Extreme 160.93
281.7
5 years 160.93
Extreme 160.93
331.68
10 years 76.27
Extreme 76.27
333.96
Manager TitleAgeSince
Chief Executive Officer - 01/10/2026
Director of Finance/CFO - 28/02/2026
Chief Tech/Sci/R&D Officer - 25/08/2025
Director TitleAgeSince
Director/Board Member 74 01/07/1999
Chairman 74 01/01/1984
Director/Board Member 69 01/01/1984
Date Insider Type Main position Quantity % Market Cap. Importance
9/10/26 Other

Director

205,860 0.0293%
9/10/26 Issuer sale

Founder

-500,000 0.0711%
9/10/26 Other

Director

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
-1.83%-2.15%+5.85%+18.13% 160B
-2.06%-0.33%+20.31%+52.52% 253B
+1.12%-3.27%-18.23%+57.21% 151B
+5.57%-2.76%-56.00%-15.61% 64.23B
+1.19%+2.62%-10.64%-8.42% 54.11B
+1.36%+2.98%+13.11%+42.32% 53.76B
-1.90%-3.51%+5.43%+61.66% 49.71B
-1.65%-2.26%+17.51%+64.63% 48.49B
-2.85%-1.41%+28.58%+83.18% 44.17B
-3.99%-16.40%+83.41%+101.84% 34.26B
Average -0.69%-2.33%+8.93%+45.74% 91.35B
Weighted average by Cap. -0.75%-1.34%+5.57%+42.73%

Financials

2026 *2027 *
Net sales 26.26B 23.45B 21.52B 19.57B 36.69B 2,486B 37.42B 257B 104B 1,312B 98.56B 96.46B 4,145B 28.28B 25.25B 23.17B 21.08B 39.52B 2,678B 40.31B 277B 112B 1,413B 106B 104B 4,464B
Net income 4.4B 3.93B 3.6B 3.28B 6.14B 416B 6.27B 43.02B 17.34B 220B 16.5B 16.15B 694B 5.22B 4.66B 4.27B 3.89B 7.29B 494B 7.43B 51.03B 20.57B 261B 19.57B 19.16B 823B
Net Debt 20.58B 18.37B 16.86B 15.34B 28.75B 1,948B 29.33B 201B 81.17B 1,028B 77.23B 75.59B 3,248B 16.09B 14.36B 13.18B 11.99B 22.48B 1,523B 22.92B 157B 63.45B 804B 60.37B 59.08B 2,539B
Projected Income Statement - Annual - Danaher Corporation
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
59,000
Date Price Change Volume
02/11/26 USD 227.97 -1.83% 3,162,025
30/10/26 USD 232.23 -2.00% 3,755,004
29/10/26 USD 236.98 +1.24% 2,702,439
28/10/26 USD 234.07 +0.89% 3,140,265
27/10/26 USD 232.00 -0.42% 2,498,143
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Danaher Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
227.97USD
Average target price
259.90USD
Spread / Average Target
+14.01%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Danaher Corporation